Skip to main content
. 2026 Feb 12;39(2):228–237. doi: 10.20524/aog.2026.1042

Table 4.

Clinical features and outcomes among patients with immune checkpoint inhibitor-related esophagitis treated with steroids vs. those not treated with steroids, n=148

graphic file with name AnnGastroenterol-39-2-228-g006.jpg